Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07658417 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec

Name: Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec — clinical trial record (NCT07658417)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ICOSWITCH REAL

StatusEnrolling by Invitation

PhaseNot specified

SponsorNovo Nordisk A/S

Started2026-07-02

View on ClinicalTrials.gov ↗

The purpose of this study is to investigate the use of insulin icodec in the real-world setting in a population that broadly reflects people living with T2D and for whom switching to a once-weekly insulin icodec has been deemed relevant and beneficial by the treating physician. The study will last for approximately 30 weeks.

Amendment history 1 change detected by DataLookout

2026-09-16

Enrolling by invitation only

Trial Details

NCT Number	NCT07658417
Lead Sponsor	Novo Nordisk A/S
Conditions	Diabetes Mellitus, Type 2
Enrollment	216 participants
Start Date	2026-07-02
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-15